No abstract available.
Hemostasis*

No abstract available.
Hemostasis* ; Thrombosis*

The hemostatic effect of endoscopic microwave coagulation method for upper gastrointestinal bleeding was evaluated clinically. Hemostasis over 72 hours was achieved in 18 of 20 cases (90%) with upper gastrointestinal bleeding by the endoscopic microwave coagulation method. It is noteworthy that this method was effective in all 4 cases of pulsatile bleeding from exposed vessels. We conclude that this method is useful for emergency endoscopic hemostasis on upper gastrointestinal bleeding, especially bleeding from exposed vessels.
Emergencies ; Hemorrhage* ; Hemostasis ; Hemostasis, Endoscopic ; Microwaves*

BACKGROUND/AIMS: Dieulafoy's lesion is a rare cause of massive upper gastrointestinal bleeding, most commonly in the proximal stomach. Although the mechanical hemostatic method has been widely used, it is difficult to access for complete application. This study evaluated the utility of a positional change in patients with a bleeding Dieulafoy's lesion. METHODS: Between January 2003 and March 2004, 15 patients with a bleeding Dieulafoy's lesion were randomly assigned to either a positional change group (right decubitus or supine, n=7) or a left decubitus group (n=8). The demographic characteristics, endoscopic variables, and clinical outcomes were analyzed. RESULTS: The patients' characteristics at entry were similar in both groups. Initial hemostasis was achieved in all patients. Recurrent bleeding developed in only one patients in the left decubitus group. The mean procedure time was significantly shorter in the positional change group than in the left decubitus group (4.5+/-3.4 min vs. 7.4+/-5.2 min, p<0.05). The ineffective hemoclip number (respectively, 0.3+/-0.1 vs. 1.4+/-1.2, p<0.05) was significantly different in the two groups. No major procedure-related complications occurred in the positional change group. CONCLUSIONS: Endoscopic hemostasis with a positional change is an effective and safe method for treating in a bleeding Dieulafoy's lesion.
Hemorrhage* ; Hemostasis ; Hemostasis, Endoscopic* ; Humans ; Stomach

120 normal subjects without bleeding history aged 20-77 were studied. Bleeding time 169 seconds, there is no significant statistic difference in genders and age groups. Plasma fibrinogen level was 2.56 g/l, no significant difference in 2 genders. In the under 45 years old group, fibrinogen level was lower than in above 45 yeas old group with statistical significant. No case of non-contracted blood clot occured, 2.5% of blood clot was contrated non completely, 97.5% completely. Alcohol test was negative in all cases. No case of fibrinolyse time < 90 minutes occured.
Hemostasis ; Blood Coagulation ; Laboratories

Although techniques and instruments for endoscopic submucosal dissection (ESD) have improved, bleeding is still the most common complication. Minimizing the occurrence of bleeding is important because blood can interfere with subsequent procedures. Generally, ESD-related bleeding can be divided into intraprocedural and postprocedural bleedings. Postprocedural bleeding can be further classified into early post-ESD bleeding which occurs within 48 hours after ESD and late post-ESD bleeding which occurs later than 48 hours after ESD. A basic principle for avoiding intraprocedural bleeding is to watch for vessels and coagulate them before cutting. Several countertraction devices have been designed to minimize intraprocedural bleeding. Methods for reducing postprocedural bleeding include administration of proton-pump inhibitors or prophylactic coagulation after ESD. Medical adhesive spray such as n-butyl-2-cyanoacrylate is also an option for preventing postprocedural bleeding. Various endoscopic treatment modalities are used for both intraprocedural and postprocedural bleeding. However, hemoclipping is infrequently used during ESD because the clips interfere with subsequent resection. Bleeding that occurs as a result of ESD can usually be managed easily. Nonetheless, more effective ways to prevent bleeding, including reliable ESD techniques, must be developed.
Adhesives ; Enbucrilate ; Hemorrhage ; Hemostasis

A wide transfixing suture including sacrum successfully controlled severe presacral hemorrhage during rectal resection. The basic principle of this technique lies in safe tamponade of injured fragile vessels attached to sacral periosteu. This technique can be equipped as one of the efficient armamentarium competing lethal presacral hemorrhage during pelvic surgery.
Hemorrhage* ; Hemostasis ; Sacrum ; Sutures*

No abstract available.
Hemorrhage* ; Hemostasis, Endoscopic* ; Humans

A technique of partial cystectomy employing for hemostasis and traction was presented in conjunction with clinic study.
Cystectomy* ; Hemostasis ; Traction

Introduction: Type 2 DM (T2DM) is associated with inflammation and vascular dysfunction which impact hemostasis. Thromboelastography (TEG) as a hemostasis assessment method, is not routinely applied in T2DM. Methodology: A cross-sectional study was conducted among T2DM patients attending the Endocrinology Clinic of Saiful Anwar Hospital, Indonesia. Glycemic profiles were determined using fasting plasma glucose (FPG), 2-hour postprandial plasma glucose (2hPPG), and glycosylated hemoglobin (HbA1c). Therapy for T2DM was classified into insulin and non-insulin regimens. The primary and secondary hemostasis profile were examined using TEG and was classified as hypo- hyper- and normo-coagulable states. Result: A total of 57 T2DM patients were included. Kruskal-Wallis test did not reveal a significant association between glycemic profiles and groups of hemostasis. However, the median HbA1c was higher in the hypercoagulable group of primary hemostasis and fibrinolysis. The median FPG and 2hPPG were higher in the normo-coagulable group of secondary hemostasis. Logistic regression did not indicate a significant association between type of therapy for diabetes and hemostasis profile. Conclusion This study did not find significant associations between glycemic levels and type of DM therapy with hemostasis profiles using the TEG method in patients with T2DM.
Diabetes Mellitus ; Thrombelastography ; Hemostasis